No Data
No Data
Earnings Preview: EVH to Report Financial Results Post-market on May 08
William Blair Maintains Evolent Health(EVH.US) With Buy Rating
Evolent Health's Promising Financial Outlook Justifies Buy Rating
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks
JMP Securities Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $13
JMP Securities Reiterates Market Outperform on Evolent Health, Maintains $13 Price Target
151798759 OP : sonething is up… fingers crossed